Skip to main content

Pharming Group N.V.

PHAR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001828316

No open-market purchases or sales by Pharming Group N.V. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $1.31M in total; no superinvestor holds it.

Superinvestors holding PHAR, Q2 2026

See all superinvestors

No superinvestor reported holding PHAR in Q2 2026.